Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation
- Author
- NICOLINI, Franck E1 ; HAYETTE, Sandrine2 ; MAHON, Francois-Xavier9 ; LE, Quoc-Hung1 ; MICHALLET, Mauricette1 ; ROCHE-LESTIENNE, Catherine10 ; PREUDHOMME, Claude11 ; CORM, Selim3 ; BACHY, Emmanuel1 ; BORIES, Dominique4 ; TULLIEZ, Michel4 ; GUILHOT, Frangois5 ; LEGROS, Laurence6 ; MALOISEL, Frédéric7 ; KILADJIAN, Jean-Jacques8
[1] Hematology Department, Hôpital E. Herriot, 69437 Lyon, France
[2] Laboratory for Hematology and Cytogenetics, Centre Hospitalier Lyon Sud, 69495 Pierre-Benite, France
[3] Hematology Department, CHRU, 59037, Lille, France
[4] Laboratory for Hematology, Hôpital Henri Mondor, 94000 Créteil, France
[5] Oncology, Cellular Therapy and Hematology Department, Hôpital J. Bernard, 86021 Poitiers, France
[6] Hematology Department, Hôpital de l'Archet, 06202 Nice, France
[7] Hematology Department, Hôpital Civil, 67100 Strasbourg, France
[8] Hematology Department, Hôpital Avicenne, 93000 Bobigny, France
[9] Laboratory for Hematology, Hôpital Pellegrin, 33076 Bordeaux, France
[10] Laboratory for Medical Genetics, Hôpital Jeanne de Flandre, CHRU 59037 and U817 Inserm Lille, France
[11] Laboratory for Hematology, Hôpital Calmette, CHRU 59037 Lille and U817 Inserm Lille, France - Source
Haematologica (Roma). 2007, Vol 92, Num 9, pp 1238-1241, 4 p ; ref : 18 ref
- ISSN
- 0390-6078
- Scientific domain
- Hematology
- Publisher
- Haematologica, Pavia
- Publication country
- Italy
- Document type
- Article
- Language
- English
- Author keyword
- BCR-ABL mutation CML T3151 imatinib mesylate
- Keyword (fr)
- Anticancéreux Chromosome C9 anormal Chromosome G22 anormal Chromosome Ph1 Gène hybride Gène onc cellulaire Génétique Homme Hématologie Imatinib Mutation Pronostic Protein kinase Résistance traitement Translocation chromosomique Gène abl Gène bcr Inhibiteur de la tyrosine kinase Leucémie myéloïde chronique Protéine bcr-abl STI 571 Aberration chromosomique Chromosome anormal Enzyme Hémopathie maligne Inhibiteur enzyme Myéloprolifératif syndrome Protein-tyrosine kinase Transferases
- Keyword (en)
- Antineoplastic agent Abnormal chromosome C9 Abnormal chromosome G22 Philadelphia chromosome Hybrid gene C-Onc gene Genetics Human Hematology Imatinib Mutation Prognosis Protein kinase Treatment resistance Chromosome translocation Chronic myelocytic leukemia Bcr-abl protein Chromosomal aberration Abnormal chromosome Enzyme Malignant hemopathy Enzyme inhibitor Myeloproliferative syndrome Protein-tyrosine kinase Transferases
- Keyword (es)
- Anticanceroso Cromosoma C9 anormal Cromosoma G22 anormal Cromosoma Ph1 Gen híbrido Gen onc celular Genética Hombre Hematología Imatinib Mutación Pronóstico Protein kinase Resistencia tratamiento Translocación cromosómica Leucemia mieloidea Aberración cromosómica Cromosoma anormal Enzima Hemopatía maligna Inhibidor enzima Mieloproliferativo síndrome Protein-tyrosine kinase Transferases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B23 Medical genetics / 002B23B Chromosome aberrations
- Discipline
- Blood diseases Medical genetics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19064183
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.3324/haematol.11369 
https://dx.doi.org/10.3324/haematol.11369
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.3324\/haematol.11369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"92\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1238\";s:8:\"\u0000*\u0000epage\";s:4:\"1241\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NICOLINI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Franck E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:17:\"HAYETTE, Sandrine\";i:1;s:22:\"MAHON, Francois-Xavier\";i:2;s:13:\"LE, Quoc-Hung\";i:3;s:21:\"MICHALLET, Mauricette\";i:4;s:26:\"ROCHE-LESTIENNE, Catherine\";i:5;s:18:\"PREUDHOMME, Claude\";i:6;s:11:\"CORM, Selim\";i:7;s:15:\"BACHY, Emmanuel\";i:8;s:17:\"BORIES, Dominique\";i:9;s:15:\"TULLIEZ, Michel\";i:10;s:17:\"GUILHOT, Frangois\";i:11;s:16:\"LEGROS, Laurence\";i:12;s:20:\"MALOISEL, Fr\u00e9d\u00e9ric\";i:13;s:23:\"KILADJIAN, Jean-Jacques\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.3324\/haematol.11369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"92\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1238\";s:8:\"\u0000*\u0000epage\";s:4:\"1241\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NICOLINI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Franck E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:17:\"HAYETTE, Sandrine\";i:1;s:22:\"MAHON, Francois-Xavier\";i:2;s:13:\"LE, Quoc-Hung\";i:3;s:21:\"MICHALLET, Mauricette\";i:4;s:26:\"ROCHE-LESTIENNE, Catherine\";i:5;s:18:\"PREUDHOMME, Claude\";i:6;s:11:\"CORM, Selim\";i:7;s:15:\"BACHY, Emmanuel\";i:8;s:17:\"BORIES, Dominique\";i:9;s:15:\"TULLIEZ, Michel\";i:10;s:17:\"GUILHOT, Frangois\";i:11;s:16:\"LEGROS, Laurence\";i:12;s:20:\"MALOISEL, Fr\u00e9d\u00e9ric\";i:13;s:23:\"KILADJIAN, Jean-Jacques\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.3324\/haematol.11369\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.3324\/haematol.11369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"92\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1238\";s:8:\"\u0000*\u0000epage\";s:4:\"1241\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NICOLINI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Franck E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:17:\"HAYETTE, Sandrine\";i:1;s:22:\"MAHON, Francois-Xavier\";i:2;s:13:\"LE, Quoc-Hung\";i:3;s:21:\"MICHALLET, Mauricette\";i:4;s:26:\"ROCHE-LESTIENNE, Catherine\";i:5;s:18:\"PREUDHOMME, Claude\";i:6;s:11:\"CORM, Selim\";i:7;s:15:\"BACHY, Emmanuel\";i:8;s:17:\"BORIES, Dominique\";i:9;s:15:\"TULLIEZ, Michel\";i:10;s:17:\"GUILHOT, Frangois\";i:11;s:16:\"LEGROS, Laurence\";i:12;s:20:\"MALOISEL, Fr\u00e9d\u00e9ric\";i:13;s:23:\"KILADJIAN, Jean-Jacques\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.3324\/haematol.11369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"92\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1238\";s:8:\"\u0000*\u0000epage\";s:4:\"1241\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NICOLINI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Franck E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:17:\"HAYETTE, Sandrine\";i:1;s:22:\"MAHON, Francois-Xavier\";i:2;s:13:\"LE, Quoc-Hung\";i:3;s:21:\"MICHALLET, Mauricette\";i:4;s:26:\"ROCHE-LESTIENNE, Catherine\";i:5;s:18:\"PREUDHOMME, Claude\";i:6;s:11:\"CORM, Selim\";i:7;s:15:\"BACHY, Emmanuel\";i:8;s:17:\"BORIES, Dominique\";i:9;s:15:\"TULLIEZ, Michel\";i:10;s:17:\"GUILHOT, Frangois\";i:11;s:16:\"LEGROS, Laurence\";i:12;s:20:\"MALOISEL, Fr\u00e9d\u00e9ric\";i:13;s:23:\"KILADJIAN, Jean-Jacques\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
